TNF-related apoptosis-inducing ligand (TRAIL) could selectively induce apoptosis of cancer cells, while the application of recombinant TRAIL protein faced the challenges of low bioavailability and resistance of cancer cells. The gene discussed is TNFSF10; the disease is cancer.